A O PHARMA SERVICES LTD

Executive Summary

A O Pharma Services Ltd presents a low solvency and liquidity risk profile based on its current balance sheet strength and compliance record. However, the company’s very recent establishment, concentrated ownership, and limited public financial disclosures suggest further due diligence is warranted to fully understand operational sustainability and governance. Overall, initial indicators are positive but incomplete financial and operational transparency warrant cautious monitoring.

A O PHARMA SERVICES LTD - Analysis Report

Company Number: 14527830

Analysis Date: 2025-07-29 14:04 UTC

1. Risk Rating: LOW
   The company demonstrates strong net current assets relative to current liabilities, positive net assets, and timely filing of accounts and confirmation statements. There are no indications of overdue filings or insolvency processes.

2. Key Concerns:

• Limited Operating History: Incorporated in December 2022, the company has just over two years of trading history, which limits the assessment of long-term operational stability.
• Single Director and Shareholder: Control is concentrated entirely in one individual, which may pose governance and succession risks.
• Minimal Fixed Assets: The company holds very low fixed assets (£389 in 2024), which may indicate limited capital investment and potential vulnerability if business conditions deteriorate.

3. Positive Indicators:

• Strong Liquidity Position: Net current assets increased significantly from £78k in 2023 to £175k in 2024, indicating healthy short-term financial strength.
• Solvent Balance Sheet: Net assets have more than doubled year-on-year, reaching £175k, suggesting positive retained earnings or capital injection.
• Compliance: All statutory filings (accounts and confirmation statements) are up to date with no overdue notices.
• Micro-entity Accounting: The company utilizes micro-entity provisions, indicating simplicity and low complexity in financial reporting.

4. Due Diligence Notes:

• Clarify Revenue and Profitability: The filings do not disclose turnover or profit and loss figures; obtaining management accounts or further financial details is recommended to assess operational performance.
• Understand Business Model and Customer Base: The SIC code (74909) is broad; further detail on the company’s specific professional or scientific activities would aid risk assessment.
• Confirm Director Background: While no disqualifications are indicated, it is prudent to review the director’s professional reputation and prior business history given sole control.
• Review Cash Flow Trends: Although current assets are strong, identifying the composition (cash vs. receivables) and cash flow sufficiency would provide a clearer liquidity picture.